A Phase III Randomized, Open-Label Comparative Study of Induction Chemotherapy Followed by Thoracic Radiation Therapy With Supplemental Oxygen, With or Without Concurrent RSR13 (Efaproxiral), in Patients With Locally Advanced Unresectable (Stage IIIA/IIIB) Non-Small Cell Lung Cancer
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 09 May 2013
At a glance
- Drugs Antineoplastics; Carboplatin; Cisplatin; Efaproxiral; Gemcitabine; Paclitaxel; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- 30 Jan 2009 Status changed from active, no longer recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 11 Oct 2005 New trial record.